Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin.
about
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathiesImmunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathiesPeripheral neuropathy: clinical and electrophysiological considerations.A case of POEMS syndrome associated with essential thrombocythaemia and dermal mastocytosis.Syndrome of plasma cell dyscrasia, polyneuropathy, and diabetes mellitus.IgG monoclonal paraproteinaemia and peripheral neuropathy.Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathyPlasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasiaTreatment of peripheral neuropathiesAnti-CNS antibodies in neurological and psychiatric disorders.Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.The role of sulfoglucuronosyl glycosphingolipids in the pathogenesis of monoclonal IgM paraproteinemia and peripheral neuropathy.Lupus/Sjögren's autoantibody specificities in sera with paraproteinsActivation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathiesIgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside.A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.Plasma cell dyscrasia and peripheral neuropathy: identification of the myelin antigens that react with human paraproteins.Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study GroupAnti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.Testing for anti-glycolipid IgM antibodies in chronic immune-mediated demyelinating neuropathies.Advances in the laboratory evaluation of peripheral neuropathies.IgM paraproteinaemia, polyneuropathy and myelin-associated glycoprotein (MAG).IgM MGUS associated with anti-MAG neuropathy: a single institution experience.Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.The Japanese plasma cell dyscrasia syndrome: case report and theory of pathogenesis.Autoantibody to nerve tissue in a patient with a peripheral neuropathy and an IgG paraprotein.Nervous system lupus: pathogenesis and rationale for therapy.Chronic immune-related demyelinating neuropathies.Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control study.The pathogenesis of neuropsychiatric lupus.Peripheral neuropathy and solitary myeloma: analysis of serum and CSF IgG in two cases.Prevalence of peripheral neuropathy in multiple myeloma at initial diagnosis.Diagnostics of anti-MAG antibody polyneuropathy.Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin-associated glycoprotein (MAG) antibodies.Anaesthesia for selective anglocardiography.Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significance.
P2860
Q24197877-423575B9-8ECF-41DD-A539-578660D200B1Q24243918-508AE131-3074-4595-A3DB-EC5AEC1F3090Q27693190-6DC9E057-548A-4B14-8B35-414EF17B401DQ33399865-3683AAF9-394C-45F1-AA60-C4706E94619CQ33557945-A7ED1892-0EC2-4B94-9FC2-5FC4405BF8F1Q33590426-AA3DFAD8-2E73-40A0-89B4-4BCC1347A708Q33591756-85D1A4B3-F519-4E04-A27D-9CC86A8E5A1BQ33620088-0108E2E9-DE93-4AB5-9743-9C270DBBF176Q33621708-E4B95D78-CD2E-4F2B-8941-CEECFE6A1190Q33629881-C099907A-58BC-4A42-979D-0049CE39EC18Q34577492-C3B6BD73-B85C-46C0-BFB2-8CA3C6EAD80CQ35208842-F33AD22E-BFE1-4305-ABEA-374B46BCBEA9Q35575699-EEEBB134-5C15-4D18-9BBE-A210333CC9BCQ35582283-D8591B40-143E-4FCE-A65F-9D7835F5DBD2Q36249946-74D342BE-14FC-42AB-9A6A-47CE0E26FE8EQ36316836-4A462651-EFF2-490D-A97A-FEC03ABAD5B3Q36380313-4543A5C5-3503-41AC-93E0-31FF1761C24EQ36880650-1E3BB0C3-FF12-416B-B185-79C6D7E6E3F0Q37677257-3B34D3C7-38F7-49F6-AEE9-3F6B5C7E6E0FQ37893214-4652DAE1-3A72-4F94-A50D-0CC716C58F04Q37965408-6C835436-B757-423B-BCB6-0AC1F7CC8702Q38156454-BFDEBC7E-DC73-46ED-ABDD-F850F9AB0F7DQ38311759-108B0D99-E28E-410B-B3AF-0AF205D380D8Q38971983-BC7B715D-5CB2-4684-B63A-0B50B3880FEDQ39121581-0F85EC1A-358C-4B00-B5EE-D5ECAE5F2610Q39374503-6DC393A9-C6A2-4ED7-B5D8-287670EDBDE9Q40929944-9FDD7DD8-0B8F-47EC-A1D3-B8B46CE5191EQ40939580-D4B83011-1BE1-48D1-8AF8-46C1C6E907E3Q41638338-B9EEFC3A-BF0A-44C4-B065-B2ECA2DF2AE8Q42055183-3DB64CFA-64C7-4B29-8F82-1AD54F6E4345Q42723486-5A74951A-4BB0-49F6-B395-F7A9578FEEDEQ43433029-59DC9DF3-F1D7-41C9-A890-6EE4E92A3736Q50067536-D407CF23-D7E1-4996-9C86-32C71A10AA9EQ50242655-0386273B-078A-433A-9942-BF3B4D5810C5Q52771919-BA6B732D-9B15-4D71-B077-9CF3556825CFQ53965800-614B560C-0EC9-4126-8AA9-54F6844DF2AE
P2860
Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Plasma-cell dyscrasia and peri ...... dy to peripheral-nerve myelin.
@en
Plasma-cell dyscrasia and peri ...... dy to peripheral-nerve myelin.
@nl
type
label
Plasma-cell dyscrasia and peri ...... dy to peripheral-nerve myelin.
@en
Plasma-cell dyscrasia and peri ...... dy to peripheral-nerve myelin.
@nl
prefLabel
Plasma-cell dyscrasia and peri ...... dy to peripheral-nerve myelin.
@en
Plasma-cell dyscrasia and peri ...... dy to peripheral-nerve myelin.
@nl
P2093
P1476
Plasma-cell dyscrasia and peri ...... dy to peripheral-nerve myelin.
@en
P2093
Osserman EF
Rowland LP
Sherman WH
P304
P356
10.1056/NEJM198009113031105
P407
P577
1980-09-01T00:00:00Z